12:00 AM
Apr 24, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Porcine fetal neural cells: Phase I study update

Diacrin Inc. (DCRN), Charlestown, Mass.
Product: Porcine fetal neural cells
Business: Gene/Cell therapy, Neurological
Therapeutic category: Cell replacement
Target: NA

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >